No other ASX listed company has a CarT (or any other type of Cell Therapy) already currently in a Human Trial. If though the trials are not being physically run in Australia, as CHM are ASX Listed they can still state they are the leaders.
Peter Mac in Melbourne are approved to manufacture an existing CAR-T therapy treatment by Novartis called Kymriah for certain B cell malignancies.
Peter Mac are also helping PTX with their next generation OmniCAR platform, but that is also still Precinical.
Recent videos over on the Media Thread are a good watch and Jennifer CEO explains the tech in very easy to follow language.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)